Researchers associated with the New York-based Memorial Sloan Kettering Cancer Center have obtained positive results in the ...

Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced the publication of data supporting the effective use of its high-density microarray patch ...

Although there are tumor suppressor genes in normal cells to prevent cancer, gene mutations can cause a normal cell to become ...

T cells are positioned at the frontline of the body's immune system to fight infection, cancer, and autoimmune disease. While ...

A research team led by Prof. LIU Chenli from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences (CAS) and Prof. XIAO ...

For decades, scientists have explored the potential of bacteria in fighting cancer, but safety and efficacy barriers have ...

Following positive results from the Phase 1 dose escalation study, BND-22 (SAR444881) is now being tested in Phase 2 trials as monotherapy for patients ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced certain operational results following approval of the permanent J-c ...

This study combines mathematical models and experimental data to analyse the emergence of heterogeneity within clonal NK cell responses during antigen-specific cell expansion. Although it comprises ...

A six-month modified Atkins diet intervention in relapsing multiple sclerosis patients led to significant immunometabolic ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...